Pregnancy after isotretinoin use;Zwangerschap na isotretinoïnegebruik

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 45, 2013, Pages

  Manders, Klaartje C ^a   De Vries, Loes C ^b   Roumen, Frans J M E ^c  

^a ELKERLIEK HOSPITAL   (Netherlands)

^b Teratologie Informatie Service   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS ETONOGESTREL; ISOTRETINOIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL DISORDER; DRUG USE; FEMALE; FETUS ECHOGRAPHY; HUMAN; PREGNANCY; PREGNANCY TERMINATION;

EID: 84891340238     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39:S34-7.
2. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. 2007;299:467-73.
3. Rosa FW. Teratogenicity of isotretinoin. Lancet. 1983;322:513.
4. Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol. 2007;63:196-205.
5. Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet. 2010;281:221-7.
6. Yook JH, Han JY, Choi JS, et al. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin. Clin Toxicol (Phila). 2012;50:896-901.
7. Gerald G. Briggs, Roger K. Freeman, Sumner J. Yaffe. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 9e gereviseerde dr. Philadelphia: Lippincott Williams and Wilkins; 2011:777-9.
8. Richtlijn Acneïforme dermatosen. Utrecht: Nederlandse Vereniging voor Dermatologie en Venereologie; 2013.
9. Samenvatting van de productkenmerken van isotretenoïne. Utrecht: College ter Beoordeling van Geneesmiddelen; 2012.
10. Isotretinoin. DrugBank. www.drugbank.ca/drugs/DB00982, geraadpleegd op 24 september 2013.